We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Vedanta Biosciences has received a research grant from CARB-X to support the development of an anti-infective to treat hospital-acquired infections by multi-drug resistant organisms (MDRO).
Cipla USA has announced the acquisition of the prescription drug ZEMDRI (Plazomicin) from Achaogen in a Chapter 11, U.S. Bankruptcy Code auction of Achaogen’s assets.